URBN
50
-2
DOW
43
-3
FLR
56
-2
OKE
78
3
FCX
57
-2
STX
55
-2
BWA
48
-5
GM
65
-7
NEM
44
-2
HST
59
7
PLD
56
-5
AKAM
50
-3
LYB
41
-2
CVS
52
-6
SJM
45
9
JWN
59
2
AVGO
27
2
PGR
68
3
PCG
93
4
XYL
49
-7
URBN
50
-2
DOW
43
-3
FLR
56
-2
OKE
78
3
FCX
57
-2
STX
55
-2
BWA
48
-5
GM
65
-7
NEM
44
-2
HST
59
7
PLD
56
-5
AKAM
50
-3
LYB
41
-2
CVS
52
-6
SJM
45
9
JWN
59
2
AVGO
27
2
PGR
68
3
PCG
93
4
XYL
49
-7
Financhill
Back

iShares Core S&P US Growth ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
78

IUSG
iShares Core S&P US Growth ETF

Last Price:
137.43
Seasonality Move:
2.48%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.50
Seasonality Move:
14.88%
Buy
78
iShares Core S&P US Growth ETF (IUSG) is a Buy

Is iShares Core S&P US Growth ETF a Buy, Sell or Hold?

  • The current iShares Core S&P US Growth ETF [IUSG] share price is $138.77. The Score for IUSG is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • IUSG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IUSG Stock Price Chart

What is iShares Core S&P US Growth ETF's stock price today?

  • The iShares Core S&P US Growth ETF share price today is $138.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IUSG is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

IUSG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.21 Buy
Relative Strength Index (14 RSI): 62.34 Buy
Chaikin Money Flow: 262716 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (133.37 - 138.53) Buy
Bollinger Bands (100): (124.87 - 135.31) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

IUSG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 137.04 Buy
20-day SMA: 136.44 Buy
50-day SMA: 134.01 Buy
200-day SMA: 124.28 Buy
8-day EMA: 137.56 Buy
20-day EMA: 136.59 Buy
50-day EMA: 134.04 Buy
200-day EMA: 124.21 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

iShares Core S&P US Growth ETF Earnings Growth & IUSG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

iShares Core S&P US Growth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):